Oruka Therapeutics, Inc. · NASDAQ:ORKA

Klein Lawrence Otto sold 2,452 Oruka Therapeutics, Inc. shares (Form 4)

Traded Sep 15, 2026 · Filed Sep 15, 2026

On Sep 15, 2026, Klein Lawrence Otto (Director, Chief Executive Officer) sold 2,452 Oruka Therapeutics, Inc. shares at US$95.71 for US$235K, leaving 923,128 shares. Filed Sep 15, 2026 (Form 4).

Sold
2,452 shares
Price
US$95.71
Value
US$235K
Holding after
923,128 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 15, 2026Common StockSale2,452US$95.71923,128Direct

Source

View original at SEC

Related